A new 'gold standard' clinical trial shows that epilepsy drug Sulthiame could vastly reduce Obstructive Sleep Apnea symptoms.

An epilepsy drug could cure a potentially ... in their symptoms of obstructive sleep apnea (OSA), say scientists. Patients ...

Sulthiame, an epilepsy drug sold under the brand name Ospolot in Europe, appeared to reduce symptoms of obstructive sleep apnea (OSA) in a late-breaking clinical trial presented at the European ...

A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame had few pauses in their breathing while asleep, as well as higher levels ...

A new dose-finding study supported the potential of the carbonic anhydrase inhibitor as an alternative to CPAP machines.

Using the apnea-hypopnea index of AHI3a, which assesses breathing interruptions during sleep, the researchers found that patients on the highest dose of sulthiame had 39.9% lower frequency of ...

Researchers said the drug could help people who don’t use Cpap machines, but that larger studies are needed to confirm the ...

An epilepsy drug could ... of obstructive sleep apnea (OSA), say scientists. Patients with OSA often snore loudly, their breathing starts and stops during the night, and they may wake up several ...

The epilepsy medication sodium valproate is linked to developmental problems in fetuses, but lab studies may now have found a ...